BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30243092)

  • 1. Silencing Bmi1 expression suppresses cancer stemness and enhances chemosensitivity in endometrial cancer cells.
    Kim M; Lee S; Park WH; Suh DH; Kim K; Kim YB; No JH
    Biomed Pharmacother; 2018 Dec; 108():584-589. PubMed ID: 30243092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside Rh2 induces apoptosis and inhibits epithelial-mesenchymal transition in HEC1A and Ishikawa endometrial cancer cells.
    Kim JH; Kim M; Yun SM; Lee S; No JH; Suh DH; Kim K; Kim YB
    Biomed Pharmacother; 2017 Dec; 96():871-876. PubMed ID: 29078265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
    Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F
    Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.
    Luo HB; Li B; Yuan WG; Xu CR
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirtuin 2 promotes cell stemness and MEK/ERK signaling pathway while reduces chemosensitivity in endometrial cancer.
    Zhao N; Guo Y; Liu P; Chen Y; Wang Y
    Arch Gynecol Obstet; 2022 Mar; 305(3):693-701. PubMed ID: 34476599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells.
    Zhu D; Wan X; Huang H; Chen X; Liang W; Zhao F; Lin T; Han J; Xie W
    Oncol Rep; 2014 Feb; 31(2):727-36. PubMed ID: 24337040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cyclin-dependent kinase 7 silencing on cisplatin sensitivity in endometrial carcinoma cells.
    Liu WX; Liu XY; Yu H; Chen Y; Hao Q
    Mol Med Rep; 2015 Mar; 11(3):1745-51. PubMed ID: 25411854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous silencing of β-catenin and signal transducer and activator of transcription 3 synergistically induces apoptosis and inhibits cell proliferation in HepG2 liver cancer cells.
    Wang XH; Liu MN; Huang P; Xu J; Liu AY; Chen J; Lv CQ; Xu RL
    Mol Med Rep; 2015 Aug; 12(2):2263-8. PubMed ID: 25845340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
    Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
    PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of Bmi-1 gene enhances chemotherapy sensitivity in human glioblastoma cells.
    Hong Y; Shang C; Xue YX; Liu YH
    Med Sci Monit; 2015 Apr; 21():1002-7. PubMed ID: 25858624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
    Alberti L; Losi L; Leyvraz S; Benhattar J
    PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. siRNA-mediated silencing of Nanog reduces stemness properties and increases the sensitivity of HepG2 cells to cisplatin.
    Alemohammad H; Motafakkerazad R; Asadzadeh Z; Farsad N; Hemmat N; Najafzadeh B; Vasefifar P; Baradaran B
    Gene; 2022 May; 821():146333. PubMed ID: 35182674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effect of arginine-specific ADP-ribosyltransferase 1 and poly(ADP-ribose) polymerase-1 on apoptosis induced by cisplatin in CT26 cells.
    Kuang J; Wang YL; Xiao M; Tang Y; Chen WW; Song GL; Yang X; Li M
    Oncol Rep; 2014 May; 31(5):2335-43. PubMed ID: 24676941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of AF-6/afadin induces cell invasion, suppresses the formation of glandular structures and might be a predictive marker of resistance to chemotherapy in endometrial cancer.
    Yamamoto T; Mori T; Sawada M; Matsushima H; Ito F; Akiyama M; Kitawaki J
    BMC Cancer; 2015 Apr; 15():275. PubMed ID: 25879875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of PPARγ gene expression on cell migration, invasion, and proliferation in endometrial cancer cells].
    Xinxin H; Meng Z; Guiyu Z
    Zhonghua Fu Chan Ke Za Zhi; 2014 May; 49(5):360-5. PubMed ID: 25030733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irradiation-induced epithelial-mesenchymal transition (EMT) related to invasive potential in endometrial carcinoma cells.
    Tsukamoto H; Shibata K; Kajiyama H; Terauchi M; Nawa A; Kikkawa F
    Gynecol Oncol; 2007 Dec; 107(3):500-4. PubMed ID: 17905419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of microRNA-194 suppresses the epithelial-mesenchymal transition in targeting stem cell transcription factor Sox3 in endometrial carcinoma stem cells.
    Gong B; Yue Y; Wang R; Zhang Y; Jin Q; Zhou X
    Tumour Biol; 2017 Jun; 39(6):1010428317706217. PubMed ID: 28618953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GRP78 induced by estrogen plays a role in the chemosensitivity of endometrial cancer.
    Luvsandagva B; Nakamura K; Kitahara Y; Aoki H; Murata T; Ikeda S; Minegishi T
    Gynecol Oncol; 2012 Jul; 126(1):132-9. PubMed ID: 22543280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication.
    Kaufhold S; Garbán H; Bonavida B
    J Exp Clin Cancer Res; 2016 May; 35():84. PubMed ID: 27225481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bmi1 gene silencing inhibits the proliferation and invasiveness of human hepatocellular carcinoma cells and increases their sensitivity to 5-fluorouracil.
    Zhang R; Xu LB; Yue XJ; Yu XH; Wang J; Liu C
    Oncol Rep; 2013 Mar; 29(3):967-74. PubMed ID: 23242307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.